The present invention is intended to provide an oily makeup cosmetic that is colorless in appearance but develops a color on application onto body surface, such as skin and lips. The present invention provides a colorless oily makeup cosmetic comprising (a) one or two dyes selected from Red No. 218 and Red No. 223, and (b) an oil agent, and a mixture of the component (a) and the component (b) at a mass ratio (a):(b) of 0.1:100 has a difference of 0.2 or less between the maximum absorbance and the minimum absorbance in a wavelength region of 500 to 600 nm. The oily makeup cosmetic may develop a color due to the component (a) on application onto body surface, such as skin and lips.

A cosmetic or dermatological preparation that contains an aqueous and a lipophilic fish egg extract for replumping skin; for increasing the incorporation of triglycerides in adipocytes; for increasing the expression of laminin, preferably of laminin-5 and most preferably of laminin-5 β sub-unit; and/or for maintaining the skin elasticity and/or resilience of human skin.

The present invention provides a composition comprising a blend of: a) a first component which is partially hydrolysed protein obtained from a potato protein source; and b) a second component which is partially hydrolysed protein obtained from a non-potato vegetable protein source; wherein the weight ratio of first component:second component in the blend is in the range 0.5:1 to 2:1. The invention also provides a personal care formulation comprising such a composition and a personal care ingredient, wherein the personal care formulation is for topical application to skin or hair. The invention further provides a method of treating hair using a composition and the use of a composition for the treatment of hair.

An oriental shampoo composition that can help maintain the health of the scalp and hair and help alleviate hair loss is provided. The shampoo composition includes, among others, 47.89% by weight of purified water; 10.00% by weight of a herbal mixed solution containing purified water, Rehmannia chinensis root extract, butylene glycol, Mentha arvensis extract, 1,2-hexanediol, Acorus gramineus root extract, Biota orientalis leaf extract, Chrysanthemum zawadskii extract, Panax ginseng root extract, Glycyrrhiza galbra (licorice) root extract, Lycinum chinense fruit extract, Morus alba bark extract, Xanthium strumarium fruit extract, and ethyl hexyl glycerin; 10.00% by weight of a mixed solution containing sodium lauryl sulfate, purified water, disodium phosphate and sodium carbonate; 10.00% by weight of a mixed solution containing purified water, TEA-lauryl sulfate and sodium benzoate; and 8.0% by weight of a mixed solution containing purified water, cocamidopropyl betaine and sodium chloride.

A hair treatment product is provided including Xanthan Gum in the amount of 0.5%-2.5% by volume, water in the amount of 20%-25% by volume, Henna powder in the amount of 25%-35% by volume, coffee grounds in the amount of 1%-3% by volume, Fenugreek in the amount of 1%-4% by volume, Aloe Vera juice in the amount of 8%-12% by volume, olive oil in the amount of 8%-13% by volume, honey in the amount of 15%-25% by volume, Saliguard PG in the amount of 0.5%-1.5% by volume, and peppermint oil in the amount of 0.5%-1.5% by volume. The hair treatment product is made by providing a first mixture including the Xanthan Gum and the water, providing a second mixture including the Henna powder, the coffee grounds, the Fenugreek, and the Aloe Vera juice, and providing a third mixture comprising the olive oil, the honey, the Saliguard PG, and the peppermint oil. The second mixture and the third mixtures are combined and mixed until homogeneous to form a fourth mixture. The fourth mixture and the first mixture are then combined and mixed until homogenous to form the hair treatment product. The method of applying the hair treatment product to a user's hair also is provided.

A composition is disclosed that includes pure silk fibroin-based protein fragments that are substantially devoid of sericin, wherein the composition has an average weight average molecular weight ranging from about 17 kDa to about 38 kDa, wherein the composition has a polydispersity of between about 1.5 and about 3.0, wherein the composition is substantially homogeneous, wherein the composition between 0 ppm to about 500 ppm of inorganic residuals, and wherein the composition includes between 0 ppm to about 500 ppm of organic residuals.

Described herein are oral care compositions comprising a deoxy sugar antimetabolite and methods of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in a subject.

The current invention relates to a homogeneous liquid composition comprising: as component (A) from 50 wt.-% to 90 wt.-% of 1,2-octanediol; as component (B) from 0.1 wt.-% to 30 wt.-% of at least one C3-C4 alkanediol and/or C3-C4 alkanetriol,
supplemented with 10 water as component (C) up to 100 wt.-%.

The current invention also relates to uses of the homogeneous liquid composition according to the invention and also pertains to a cosmetic, pharmaceutical, dermatological or hygienic product comprising a homogeneous liquid composition 15 according to the invention.

Disclosed is a powder composition consisting essentially of Magnolia officinalis bark extract comprising magnolol and honokiol, tocopherol or tocopherol acetate, lecithin, at least one gum, and optionally water, wherein the composition is in powdered form.

Systems and methods for mixing an oral care formulation base with one or more oral care additives in-situ. In one aspect, the invention can be a method of making an oral care formulation for consumer use, the method comprising: a) providing a first dose of an oral care formulation base to an oral cavity of a test subject; b) dispensing one or more oral care additives to the oral cavity in accordance with a first dispensing regimen during the performance of step a), the one or more oral care additives mixing with the first dose of the oral care formulation base in-situ within the oral cavity of the test subject; c) obtaining feedback regarding effects experienced by the test subject during the performance of step b); and d) creating the oral care formulation for consumer use based, at least in part, on the feedback of step c).